Skip to search formSkip to main contentSkip to account menu

iodoxamic acid

Known as: 3,3'-((1,16-dioxo-4,7,10,13-tetraoxahexadecane-1,16-dily)diimino)bis(2,4,6-triiodobenzoic acid), iodoxamidic acid, iodoxaminic acid 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1982
1982
The usefulness of iotroxic acid (5 g iodine/100 ml) (IT) for cholegraphy by drip intravenous infusion was clinically studied in… 
1979
1979
The dynamic method originally developed for studying the capacity-limited kinetics of the cholecystographic agents iodoxamic acid… 
1979
1979
A dynamic infusion method, originally developed for the pharmacokinetic studies of Iodoxamic acid, was applied to the kinetic… 
1979
1979
No differences could be detected subjectively in the quality of cholangiograms after the use of varying amounts of contrast… 
1978
1978
The previously reported steady-state method allowed estimation of the capacity-limited pharmacokinetics of the cholangiographic… 
1978
1978
Bile flow and the biliary excretion of indocyanine green, bromcresol green, eosine, bromsulphthalein-glutathione conjugate (BSP… 
1976
1976
The biotransformation of the 131I-labeled cholegraphic media ioglycamic acid, iodoxamic acid and iotroxic acid in man is… 
1976
1976
Pharmaco-kinetic studies of the cholecystographic contrast medium iodoxaminic acid (Diglumin-Iodaxamate) which is characterised… 
1976
1976
  • F. Keiner
  • Medizinische Klinik
  • 1976
  • Corpus ID: 32482488
Intravenous contrast media must have an optimum biliary excretion and a small urinary excretion, also a good tolerability. These…